Clinical Trial Update: Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing sildenafil with low molecular weight heparin for fetal growth restriction; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Ain Shams University | Conditions: Fetal Growth Abnormality, Fetal Growth Restriction | Phase 3 | Status: UNKNOWN